HA

Herve Affagard

Europe, Rhone-Alpes, France, Lyon

Description

Hervé Affagard has led MaaT Pharma since its inception phase in 2014. Notably, he was awarded Entrepreneur of the Year in Healthcare (2016) ...

Investor Profile

Herve Affagard has made 1 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • France (100%)

Industry Focus

  • Biotechnology
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Herve Affagard frequently co-invest with?

Seventure Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
B
North America, California, United States, San Bruno
Co-Investments: 1
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 1

What are some of recent deals done by Herve Affagard?

MaaT Pharma

Lyon, Rhone-Alpes, France

MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up.

BiotechnologyHealth Care
Post Ipo EquityMay 15, 2024
Amount Raised: $19,816,793